NSD1 mutations generate a genome-wide DNA methylation signature

Nature Communications

Volumn 6, Issue , 2015, Pages

  Choufani, S ^a   Cytrynbaum, C ^a,b   Chung, B H Y ^c   Turinsky, A L ^a   Grafodatskaya, D ^a   Chen, Y A ^a,b   Cohen, A S A ^d   Dupuis, L ^a,b   Butcher, D T ^a   Siu, M T ^a   Luk, H M ^e   Lo, I F M ^e   Lam, S T S ^e   Caluseriu, O ^f   Stavropoulos, D J ^a,b   Reardon, W ^g   Mendoza Londono, R ^a,h   Brudno, M ^a,h   Gibson, W T ^d   Chitayat, D ^a,b,h,i   Weksberg, R ^a,b,h   more..

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF HONG KONG   (Hong Kong)

^d Family Research Institute   (United States)

^e DEPARTMENT OF HEALTH   (Hong Kong)

^f UNIVERSITY OF ALBERTA   (Canada)

^g OUR LADY S CHILDREN S HOSPITAL   (Ireland)

^h UNIVERSITY OF TORONTO   (Canada)

ⁱ MOUNT SINAI HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GENOMIC DNA; HISTONE METHYLTRANSFERASE; NSD1 PROTEIN, HUMAN; NUCLEAR PROTEIN; SIGNAL PEPTIDE;

CELLS AND CELL COMPONENTS; CYTOGENETICS; DISEASE; DNA; GENOME; METHYLATION; MORPHOGENESIS; MUTATION; PATHOGENICITY;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DNA METHYLATION; FEMALE; GENE EXPRESSION; GENE MUTATION; GENETIC ASSOCIATION; GENETIC VARIABILITY; HUMAN; INFANT; LOSS OF FUNCTION MUTATION; MALE; MISSENSE MUTATION; MOLECULAR PATHOLOGY; NERVE CELL DIFFERENTIATION; NEWBORN; PATHOGENICITY; SOTOS SYNDROME; GENE EXPRESSION REGULATION; GENETICS; HUMAN GENOME; METABOLISM; MUTATION;

DNA METHYLATION; GENE EXPRESSION REGULATION; GENOME, HUMAN; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MUTATION; NUCLEAR PROTEINS; SOTOS SYNDROME;

EID: 84951269576     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms10207     Document Type: Article

References (23)

1. Sotos, J. F., Dodge, P. R., Muirhead, D., Crawford, J. D. & Talbot, N. B. Cerebral gigantism in childhood. A syndrome of excessively rapid growth and acromegalic features and a nonprogressive neurologic disorder. N. Engl. J. Med. 271, 109-116 (1964).
2. Baujat, G. & Cormier-Daire, V. Sotos syndrome. Orphanet J. Rare Dis. 2, 36 (2007).
3. Tatton-Brown, K. & Rahman, N. Sotos syndrome. Eur. J. Hum. Genet. 15, 264-271 (2007).
4. Kurotaki, N. et al. Haploinsufficiency of NSD1 causes Sotos syndrome. Nat. Genet. 30, 365-366 (2002).
5. Stec, I. et al. WHSC1, a 90kb SET domain-containing gene, expressed in early development and homologous to a Drosophila dysmorphy gene maps in the Wolf-Hirschhorn syndrome critical region and is fused to IgH in t(4;14) multiple myeloma. Hum. Mol. Genet. 7, 1071-1082 (1998).
6. Lucio-Eterovic, A. K. et al. Role for the nuclear receptor-binding SET domain protein 1 (NSD1) methyltransferase in coordinating lysine 36 methylation at histone 3 with RNA polymerase II function. Proc. Natl Acad. Sci. USA 107, 16952-16957 (2010).
7. Cedar, H. & Bergman, Y. Linking DNA methylation and histone modification: patterns and paradigms. Nat. Rev. Genet. 10, 295-304 (2009).
8. Grafodatskaya, D. et al. Multilocus loss of DNA methylation in individuals with mutations in the histone H3 lysine 4 demethylase KDM5C. BMC Med. Genomics 6, 1 (2013).
9. Chen, Y. A. et al. Discovery of cross-reactive probes and polymorphic CpGs in the Illumina Infinium HumanMethylation450 microarray. Epigenetics 8, 203-209 (2013).
10. 2 cause Weaver syndrome. Am. J. Hum. Genet. 90, 110-118 (2012).
11. 2 cause Weaver syndrome and increased human height. Oncotarget 2, 1127-1133 (2011).
12. Thusberg, J., Olatubosun, A. & Vihinen, M. Performance of mutation pathogenicity prediction methods on missense variants. Hum. Mutat. 32, 358-368 (2011).
13. Adzhubei, I. A. et al. A method and server for predicting damaging missense mutations. Nat. Methods 7, 248-249 (2010).
14. Reva, B., Antipin, Y. & Sander, C. Predicting the functional impact of protein mutations: application to cancer genomics. Nucleic Acids Res. 39, e118 (2011).
15. Sim, N. L. et al. SIFT web server: predicting effects of amino acid substitutions on proteins. Nucleic Acids Res. 40, W452-W457 (2012).
16. Schwarz, J. M., Rodelsperger, C., Schuelke, M. & Seelow, D. MutationTaster evaluates disease-causing potential of sequence alterations. Nat. Methods 7, 575-576 (2010).
17. Ferrer-Costa, C. et al. PMUT: a web-based tool for the annotation of pathological mutations on proteins. Bioinformatics 21, 3176-3178 (2005).
18. Rayasam, G. V. et al. NSD1 is essential for early post-implantation development and has a catalytically active SET domain. EMBO J. 22, 3153-3163 (2003).
19. Huang da, W., Sherman, B. T. & Lempicki, R. A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 4, 44-57 (2009).
20. McLean, C. Y. et al. GREAT improves functional interpretation of cis-regulatory regions. Nat. Biotechnol. 28, 495-501 (2010).
21. Luscan, A. et al. Mutations in SETD2 cause a novel overgrowth condition. J. Med. Genet. 51, 512-517 (2014).
22. Tatton-Brown, K. et al. Mutations in the DNA methyltransferase gene DNMT3A cause an overgrowth syndrome with intellectual disability. Nat. Genet. 46, 385-388 (2014).
23. Berdasco, M. et al. Epigenetic inactivation of the Sotos overgrowth syndrome gene histone methyltransferase NSD1 in human neuroblastoma and glioma. Proc. Natl Acad. Sci. USA 106, 21830-21835 (2009).